[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Dahl, 2016 - Google Patents

Biochemical and functional characterization of RhoSAP: A RhoGAP of the postsynaptic density

Dahl, 2016

View PDF
Document ID
3127437526786603523
Author
Dahl J
Publication year

External Links

Snippet

Glutamatergic synapses in the central nervous system are characterized by an electron dense network of proteins underneath the postsynaptic membrane including cell adhesion molecules, cytoskeletal proteins, scaffolding and adaptor proteins, membrane bound …
Continue reading at citeseerx.ist.psu.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/566—Immunoassay; Biospecific binding assay using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5032—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on intercellular interactions

Similar Documents

Publication Publication Date Title
Okashah et al. Variable G protein determinants of GPCR coupling selectivity
Cao et al. De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
Bigenzahn et al. LZTR1 is a regulator of RAS ubiquitination and signaling
Chinthalapudi et al. The interaction of talin with the cell membrane is essential for integrin activation and focal adhesion formation
Swaney et al. A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity
Saito et al. The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2
Wescott et al. Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices
Becker-Santos et al. Nuclear factor I/B: a master regulator of cell differentiation with paradoxical roles in cancer
Shimizu et al. A quantitative analysis of signal transduction from activin receptor to nucleus and its relevance to morphogen gradient interpretation
Lowey et al. Common structural motifs for the regulation of divergent class II myosins
Luo et al. Single‐step protease cleavage elution for identification of protein–protein interactions from GST pull‐down and mass spectrometry
Sohn et al. The adenovirus E4-ORF3 protein functions as a SUMO E3 ligase for TIF-1γ sumoylation and poly-SUMO chain elongation
Perez et al. Identification of two isoforms of the Cak receptor kinase that are coexpressed in breast tumor cell lines.
Liaño-Pons et al. The multiple faces of MNT and its role as a MYC modulator
Fatima et al. Interactome of the negative regulator of nuclear import BRCA1-binding protein 2
Wang et al. Calmodulin and PI (3, 4, 5) P3 cooperatively bind to the Itk pleckstrin homology domain to promote efficient calcium signaling and IL-17A production
Kaisari et al. Intermediates in the assembly of mitotic checkpoint complexes and their role in the regulation of the anaphase-promoting complex
McClendon et al. Structure, function, and regulation of the SRMS tyrosine kinase
Finton et al. ARTEMIS: A novel mass-spec platform for HLA-restricted self and disease-associated peptide discovery
Palmieri et al. Scorpins in the DNA damage response
Dahl Biochemical and functional characterization of RhoSAP: A RhoGAP of the postsynaptic density
Grigoriev et al. Tissue transglutaminase expression in breast carcinomas.
Zabielska-Koczywąs et al. Proteomic differences in feline fibrosarcomas grown using doxorubicin-sensitive and-resistant cell lines in the chick embryo model
Shalev et al. The PXDLS linear motif regulates circadian rhythmicity through protein–protein interactions
Siddiqui et al. Chromosome 17 missing proteins: Recent progress and future directions as part of the neXt-MP50 challenge